Serological Assays Estimate Highly Variable SARS-CoV-2 Neutralizing Antibody Activity in Recovered COVID-19 Patients

Larry L. Luchsinger, Brett Ransegnola, Daniel Jin, +17

Journal of Clinical Microbiology

VaccinationModest Antibody LevelsLong CovidViral DiagnosticsMedicine +10

Drugs that target early stages of Onchocerca volvulus: A revisited means to facilitate the elimination goals for onchocerciasis

S Jawahar, Nancy Tricoche, Christina A. Bulman, +2

PLoS neglected tropical diseases

Yeast-expressed recombinant protein of the receptor-binding domain in SARS-CoV spike protein with deglycosylated forms as a SARS vaccine candidate

Wen‐Hsiang Chen, Lanying Du, Shivali Chag, +11

Human Vaccines & Immunotherapeutics

VaccinationRbd Vaccine CandidateVaccine DevelopmentRbd ProteinReceptor-binding Domain +13

Repurposing Auranofin as a Lead Candidate for Treatment of Lymphatic Filariasis and Onchocerciasis

Christina A. Bulman, Chelsea M. Bidlow, Sara Lustigman, +22

PLoS neglected tropical diseases

Parasitic DiseaseIc50 ValuesLead CandidateAntiparasitic AgentRiver Blindness +10

Repositioning of an existing drug for the neglected tropical disease Onchocerciasis

Christian Johannes Gloeckner, Amanda L. Garner, Fana B. Mersha, +6

Proceedings of the National Academy of Sciences

Protection against Chronic Hepatitis C Virus Infection after Rechallenge with Homologous, but Not Heterologous, Genotypes in a Chimpanzee Model

Alfred M. Prince, Betsy Brotman, Dong Hun Lee, +4

The Journal of Infectious Diseases

VaccinationViral PersistenceVaccine DevelopmentHepatitis CViral Hepatitis +13

Exposure to low infective doses of HCV induces cellular immune responses without consistently detectable viremia or seroconversion in chimpanzees

Mohamed Tarek M. Shata, Nancy Tricoche, Marion E. Perkus, +8

Virology

VaccinationViral PersistenceMedicineAnimal VirusImmunology +6

Serological Assays Estimate Highly Variable SARS-CoV-2 Neutralizing Antibody Activity in Recovered COVID19 Patients

Larry L. Luchsinger, Brett Ransegnola, Daniel Jin, +17

DNA Immunization with Hepatitis C Virus (HCV) Polycistronic Genes or Immunization by HCV DNA Priming-Recombinant Canarypox Virus Boosting Induces Immune Responses and Protection from Recombinant HCV-Vaccinia Virus Infection in HLA-A2.1-Transgenic Mice

Preeti Pancholi, Marion E. Perkus, Nancy Tricoche, +2

Journal of Virology

DNA Prime–Canarypox Boost with Polycistronic Hepatitis C Virus (HCV) Genes Generates Potent Immune Responses to HCV Structural and Nonstructural Proteins

Preeti Pancholi, Qingyan Liu, Nancy Tricoche, +3

The Journal of Infectious Diseases